An updated guideline on the management of Sjögren disease has been produced by the British Society for Rheumatology, providing practical advice for healthcare professionals and the people they treat. Medscape Medical News
Glaukos Announces First Quarter 2024 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Retina World Congress 2024 to highlight scientific, clinical advancements
One thousand physicians, health care providers and industry members will gather in Fort Lauderdale, Florida, in May for the Retina World Congress 2024 hosted in conjunction with Healio Live.The meeting will bring together 165 faculty members to discuss…
Vesigen to Present New Preclinical Data on Ophthalmology Applications of Engineered ARMMs at 2024 ARVO Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)– #ARMMs–Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that the Company will be presenting tw…
Address ocular surface disease before cataract surgery for better outcomes
Ocular surface disease must be addressed before cataract surgery to ensure patient satisfaction and good surgical outcomes, according to a presentation at Real World Ophthalmology.“Ocular surface disease is quite prevalent in cataract surgery patients,…
Aurion Biotech completes enrollment in phase 1/2 corneal edema cell therapy trial
Subject dosing is complete in a phase 1/2 clinical trial of an allogeneic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release.AURN001 (Aurion Biotech) is a combination cell therapy …